RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now come up with a way to produce these particles much more quickly, and with more precise control over their size and shape.This new process, which can be run automatically without any human intervention, could greatly speed up the development of new RNA and DNA therapeutics, the researchers say. “This method can help you determine what are the parameters that will generate specific size and shape attributes, before you take those particles and see which one will perform best,” says Cedric Devos, an MIT postdoc and one of the lead authors o...